Precision billing for clinical laboratories and pathology practices
Laboratory billing requires expertise in CLIA compliance, Medicare Clinical Laboratory Fee Schedule management, ABN protocols, and complex molecular diagnostics coding. VOPSS ensures your lab captures maximum reimbursement while maintaining full regulatory compliance.
Clean Claim Rate
0%
CLIA Compliance
0%
Days in A/R
<0
Denial Rate
<0%
Why laboratory billing demands specialized expertise
Clinical laboratory billing operates under a unique regulatory and reimbursement framework that differs substantially from standard physician billing. Labs must navigate Medicare's Clinical Laboratory Fee Schedule with its annually updated maximum allowable rates, comply with CLIA certification requirements that restrict which tests can be billed based on certificate level, manage Advance Beneficiary Notice requirements for tests that may not meet medical necessity criteria, and handle complex molecular diagnostics coding for genetic and genomic testing.
VOPSS provides laboratory-specific billing specialists with deep expertise across all testing disciplines including clinical chemistry, hematology, microbiology, immunology, molecular diagnostics, anatomic pathology, and cytopathology. Our team understands the nuanced differences between reference laboratory billing, hospital outreach laboratory billing, and physician office laboratory billing, ensuring that each testing scenario is handled with the correct billing methodology and payer routing.
Common laboratory billing errors that impact collections
Laboratory billing errors are among the most costly in healthcare because labs process thousands of tests daily, and even small per-test errors compound into significant revenue losses. The most common issues include submitting claims with incorrect or missing diagnosis codes that fail medical necessity requirements, billing for tests outside the lab's CLIA certificate scope, failing to obtain ABNs for tests with known coverage limitations, and using outdated CPT codes for tests that have been reassigned or deleted in annual code updates.
Molecular diagnostic and genetic testing billing adds another layer of complexity. Many advanced molecular tests require specific prior authorization, have limited coverage determinations, and use proprietary CPT codes or Multianalyte Assays with Algorithmic Analyses (MAAA) codes that are not covered by all payers. Reference laboratory anti-markup rules, specimen sourcing documentation, and performing lab NPI requirements create additional compliance considerations that, if not managed properly, result in claim denials and potential fraud liability.
How VOPSS maximizes laboratory revenue
CLIA Compliance Management
Verification that all billed tests match your CLIA certificate level, with automated alerts for certificate renewal deadlines and scope changes.
ABN Protocol Management
Systematic ABN tracking for Medicare beneficiaries, including frequency limit monitoring, medical necessity diagnosis pairing, and proper ABN documentation.
CLFS Rate Optimization
Monitoring of annual Clinical Laboratory Fee Schedule updates, PAMA rate adjustments, and identification of tests qualifying for ADLT or MolDX pathways.
Molecular Diagnostics Coding
Expert coding for PLA codes, MAAA codes, GSP (Genomic Sequencing Procedures), and proprietary molecular test billing including LCD compliance.
Reference Lab Compliance
Proper modifier 90 application, anti-markup rule compliance, performing lab NPI management, and split billing coordination.
High-Volume Processing
Scalable billing workflows designed for high-throughput laboratory environments, processing thousands of test claims daily with same-day turnaround.
Increasing net collections by 19% for a multi-discipline reference laboratory
A regional reference laboratory processing 3,000+ tests daily was experiencing high denial rates from medical necessity failures, ABN compliance gaps, and incorrect CLIA number assignment on outreach specimen claims. VOPSS implemented automated ABN tracking, corrected CLIA billing workflows, and optimized diagnosis code pairing for high-volume test panels.
“VOPSS understood the unique challenges of reference lab billing from day one. Their ABN compliance system alone recovered thousands in previously denied Medicare claims. Our net collections increased significantly within the first quarter.”— Dr. Karen Mitchell, PhD, Laboratory Director
Denial Rate
14% → 1.6%
Days in A/R
38 → 19 Days
Net Collection Increase
+19.3% in 90 Days
Laboratory Billing FAQs
What CPT codes are commonly used in laboratory billing?
Laboratory billing utilizes a broad range of CPT codes organized by test type. Common chemistry panel codes include 80048 (basic metabolic panel), 80053 (comprehensive metabolic panel), and 80061 (lipid panel). Hematology codes include 85025 (CBC with differential) and 85027 (CBC without differential). Microbiology codes include 87081 (culture identification), 87070 (bacterial culture), and 87186 (sensitivity testing). Molecular testing uses codes like 87491 (chlamydia), 87591 (gonorrhea), and 87798 (infectious agent detection). Each code has specific specimen, methodology, and documentation requirements.
How do you handle Medicare's Clinical Laboratory Fee Schedule?
Medicare reimburses laboratory tests under the Clinical Laboratory Fee Schedule (CLFS), which sets maximum allowable rates for each CPT code. PAMA (Protecting Access to Medicare Act) further adjusted these rates based on private payer data. VOPSS ensures claims are submitted with correct CLFS-applicable codes, monitors annual rate changes, and identifies tests that may qualify for higher reimbursement under the Molecular Diagnostics Program or the Advanced Diagnostic Laboratory Tests (ADLT) pathway.
What is an ABN and when is it required?
An Advance Beneficiary Notice of Noncoverage (ABN) is a form that notifies Medicare beneficiaries when a test may not be covered. ABNs are required when a lab expects Medicare may deny a test due to frequency limitations, medical necessity questions, or coverage restrictions. VOPSS manages ABN compliance by tracking test frequency limits, identifying tests that require medical necessity documentation through ICD-10 diagnosis pairing, and ensuring ABNs are obtained and properly documented before specimen collection.
How do you manage CLIA compliance in lab billing?
Clinical Laboratory Improvement Amendments (CLIA) compliance directly impacts billing eligibility. Labs can only bill for tests that fall within their CLIA certificate level (waived, moderate complexity, or high complexity). VOPSS verifies that all billed tests match the performing laboratory's CLIA certificate type and number, and that the correct CLIA number is included on every claim. We also monitor CLIA certificate renewal dates to prevent billing disruptions.
Do you support reference laboratory billing?
Yes, we manage complete reference laboratory billing including specimen tracking across ordering and performing labs, proper modifier 90 application for reference lab services, correct NPI assignment for the performing laboratory, and compliance with anti-markup rules that restrict referring labs from billing Medicare at rates higher than the performing lab's charge. We also handle split billing scenarios where technical and professional components are performed at different locations.
What reporting do you provide for laboratory billing?
Our laboratory-specific reporting dashboard tracks collections by test category (chemistry, hematology, microbiology, molecular, pathology), denial rates by CPT code and payer, ABN compliance rates, test utilization trends, referring physician volume analysis, CLFS reimbursement variance tracking, and accounts receivable aging by payer. This provides laboratory directors with complete financial visibility.
Related RCM Services
Ready to optimize your laboratory billing?
Request a free lab billing audit. We will review your test-level denial patterns, CLIA compliance, and ABN management to identify revenue recovery opportunities.